THE EFFECT OF COMBINATION THERAPY WITH SYSTEMIC MEGLUMINE ANTIMONIATE (GLUCANTIME) AND PENTOXIFYLLINE IN THE TREATMENT OF CUTANEOUS LEISHMANIASIS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SADEGHIAN G.; NILFOROUSHZADEH MOHAMMAD ALI

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Dermatology Year:2006 | Volume:9 | Issue:1 (35) Page(s): 17-21

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

919

Download:

Cites:

Information Journal Paper

Title

THE EFFECT OF COMBINATION THERAPY WITH SYSTEMIC MEGLUMINE ANTIMONIATE (GLUCANTIME) AND PENTOXIFYLLINE IN THE TREATMENT OF CUTANEOUS LEISHMANIASIS

Author(s)

SADEGHIAN G. | NILFOROUSHZADEH MOHAMMAD ALI | Issue Writer Certificate

Keywords

CUTANEOUS LEISHMANIASISQ4

GLUCANTIMEQ3

PENTOXIFYLLINEQ3

Abstract

Background and aim: CUTANEOUS LEISHMANIASIS is a common parasitic disease in Iran specially in Isfahan. The first line of treatment for this disease are antimonial compounds, however, because of the increasing unresponsiveness and significant side effects alternative therapeutic measures have been advocated. This study was performed to evaluate the efficacy of meglumine antimoniate (Glucantime) plus PENTOXIFYLLINE in the treatment of CUTANEOUS LEISHMANIASIS. Materials and Methods: This double blind randomized controlled clinical trial with simple sampling was perfonned on 64 patients with CUTANEOUS LEISHMANIASIS referred to Skin Diseases and Leishmaniasis Research Center. The patients were randomly divided in two groups. One group was treated with systemic GLUCANTIME combined with PENTOXIFYLLINE and the other group was treated with GLUCANTIME plus placebo for 20 days and the patients were followed up for 3 months. The response to treatment was categorized into complete improvement (the lesions had been flattened, there was no induration and epidennal creases had been appeared), partial improvement (reduction in the size of the lesions, but without appearance of epidennal creases) and poor response (no reduction in the size of lesions). Results: Of 64 participants 32 patients in trial group and 31 patients in control group were followed for 3 months. After this time complete improvement, partial improvement and poor response to treatment were 81.3% , 12.5% and 6.2% in trial group and 52% , 29% and 19% in control group; respectively(P=0.04). We also observed no adverse effects due to PENTOXIFYLLINE. Conclusion: Combined therapy with GLUCANTIME plus PENTOXIFYLLINE was more effective than GLUCANTIME alone.

Cites

No record.

References

No record.

Cite

APA: Copy

SADEGHIAN, G., & NILFOROUSHZADEH, MOHAMMAD ALI. (2006). THE EFFECT OF COMBINATION THERAPY WITH SYSTEMIC MEGLUMINE ANTIMONIATE (GLUCANTIME) AND PENTOXIFYLLINE IN THE TREATMENT OF CUTANEOUS LEISHMANIASIS. IRANIAN JOURNAL OF DERMATOLOGY, 9(1 (35)), 17-21. SID. https://sid.ir/paper/57726/en

Vancouver: Copy

SADEGHIAN G., NILFOROUSHZADEH MOHAMMAD ALI. THE EFFECT OF COMBINATION THERAPY WITH SYSTEMIC MEGLUMINE ANTIMONIATE (GLUCANTIME) AND PENTOXIFYLLINE IN THE TREATMENT OF CUTANEOUS LEISHMANIASIS. IRANIAN JOURNAL OF DERMATOLOGY[Internet]. 2006;9(1 (35)):17-21. Available from: https://sid.ir/paper/57726/en

IEEE: Copy

G. SADEGHIAN, and MOHAMMAD ALI NILFOROUSHZADEH, “THE EFFECT OF COMBINATION THERAPY WITH SYSTEMIC MEGLUMINE ANTIMONIATE (GLUCANTIME) AND PENTOXIFYLLINE IN THE TREATMENT OF CUTANEOUS LEISHMANIASIS,” IRANIAN JOURNAL OF DERMATOLOGY, vol. 9, no. 1 (35), pp. 17–21, 2006, [Online]. Available: https://sid.ir/paper/57726/en

Related Journal Papers